ALK
Dawn Hezel has over five years of experience as a Medical Science Liaison. Dawn currently holds the position of Senior Principal Medical Science Liaison at ALK since December 2023. Prior to this, they worked at Sobi - North America as a Senior MSL from June 2021 to December 2023. Dawn also has experience as a Medical Science Liaison at Aimmune Therapeutics from January 2020 to June 2021 and at Kedrion Biopharma from August 2018 to January 2020.
Dawn Hezel received their Bachelor of Science in Nursing (BSN) from Roberts Wesleyan University. Dawn then went on to complete a Master of Science in Nursing (MSN) with a focus on Pediatric Nurse Practitioner at Stony Brook University. Currently, they are pursuing a Doctor of Nursing Practice (DNP) in Nursing Science at Post University, which they are expected to complete in 2023.
This person is not in any offices
ALK
8 followers
ALK-Abelló, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy products for the prevention and treatment of allergy.